D
Crinetics Pharmaceuticals, Inc. CRNX
$34.47 -$0.57-1.63%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -298.41M -277.91M -258.54M -235.46M -214.53M
Total Depreciation and Amortization 2.79M 2.26M 1.76M 1.29M 1.10M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 58.02M 55.60M 51.20M 44.31M 39.08M
Change in Net Operating Assets 11.64M 20.24M 27.25M 11.42M 8.04M
Cash from Operations -225.97M -199.81M -178.33M -178.45M -166.31M
Capital Expenditure -3.84M -3.75M -6.72M -6.00M -4.69M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -570.97M -116.29M -327.21M -242.86M -195.73M
Cash from Investing -574.82M -120.04M -333.94M -248.86M -200.41M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 1.06B 512.56M 813.05M 820.58M 411.68M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -49.44M -18.24M -38.18M -38.55M -22.74M
Cash from Financing 1.01B 494.32M 774.87M 782.03M 388.94M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 209.65M 174.47M 262.61M 354.73M 22.22M
Weiss Ratings